The effect of pregabalin on the tourniquet induced ischemia-reperfusion injury. A Prospective Randomized Study.
Backgroud: The aim of study was to investigate the efficacy of pregablin on ischemia-reperfusion injury. Fifty-four patients were randomly assigned into two groups. Pregabalin 150mg tablet was given the night and one hour before operation in the Group P (pregabalin, n=27). Placebo was given in the Group C (control, n=27) in the same times. After combined spinal-epidural anesthesia was performed, venous blood samples were taken before tourniquet inflation (t1), right before tourniquet deflation (t2) and 20 min after tourniquet deflation (t3) for the analysis of total antioxidant status (TAS), total oxidant status (TOS), catalase (CAT), ischemia-modified albumin (IMA). TAS that was primary outcome, between groups was not significantly in t3 period. However, TAS in the Group P was significantly higher in the t3 period than the t2 period [mean±SD, 0.46±0.1 vs 0.38±0.2 mmol of Trolox-equivalent/L, respectively; p<0.05]. The CAT level in the t3 period was significantly higher in the Group P than the Group C [mean±SD, 53.04±32.1 vs 35.46 ±17.2 µmol/formaldehyde, respectively; p<0.05]. In the t3 period, TOS was significantly lower in the Group P than the Group C [mean±SD, 11.97±5 vs 18.29 ±9.9 pg/mL, respectively; p<0.05]. TOS in the Group P was significantly lower in the t3 period than the t2 period. [mean ± SD, 11.97 ± 5 vs 18.98 ± 10.7 pg/ml respectively; p < 0.0001]. Pregabalin has no markedly antioxidant activity. But, it contributes to the antioxidant defense system of organism.